Juvena Therapeutics operates as a biotechnology company. It discovers protein-based therapeutics that promote tissue regeneration in the elderly, with initial clinical targets of sarcopenia and muscle regeneration. It focuses on fields that include neuromuscular therapies, osteoarthritis, cardio-metabolic, pulmonary and other therapies. It was founded in 2017 and is based in Redwood City, California.